| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2018-06-01 | nemorexant (ACT-541468) | insomnia | 3 | Idorsia (Switzerland) | CNS diseases |
| 2018-05-29 | OLX10010 | hypertrophic scar | 1 | Olix Pharmaceuticls (South Korea) | Dermatological diseases |
| 2018-05-26 | atezolizumab (MPDL3280A) and daratumumab | solid tumors | 1b | Janssen Biotech, a J&J company (USA - NJ) | Cancer - Oncology |
| 2018-05-25 | THR-149 | diabetic macular edema | 1 | Thrombogenics (Belgium) | Ophtalmological diseases |
| 2018-05-24 | BB-401 | head and neck squamous cell carcinoma (HNSCC) | 2 | Benitec Biopharma (Australia) | Cancer - Oncology |
| 2018-05-24 | TriMix-MEL (ECI-006) | metastatic melanoma | 1 | eTheRNA immunotherapies (Belgium) | Cancer - Oncology |
| 2018-05-18 | burosumab - KRN23 | X-Linked hypophosphatemia | 3 | Ultragenyx Pharmaceutical (USA - CA) Kyowa Hakko Kirin (Japan) | Rare diseases - Genetic diseases - Metabolic diseases |
| 2018-05-18 | remetinostat | early-stage cutaneous T-cell lymphoma (CTCL) | 2 | Medivir (Sweden) | Cancer - Oncology |
| 2018-05-17 | pamiparib (BGB-290) | platinum-sensitive recurrent ovarian cancer | 3 | BeiGene (China) | Cancer - Oncology |
| 2018-05-17 | SYNT001 | pemphigus (vulgaris or foliaceus) | 1-2 | Syntimmune (USA - MA) | Autoimmune diseases - Rare diseases |
| 2018-05-14 | ARO-HBV | chronic hepatitis B virus (HBV) infection | 1-2 | Arrowhead Pharmaceuticals (USA - CA) | Infectious diseases |
| 2018-05-09 | brilacidin-OM oral rinse | oral mucositis in patients undergoing chemoradiation therapy for head and neck cancer | 2 | Cellceutix (USA - MA), now Innovation Pharmaceuticals (USA - MA) | Cancer - Oncology |
| 2018-05-08 | ALG.APV-527 | 5T4-expressing solid tumors. | preclinical | Alligator Bioscience (Sweden) Aptevo Therapeutics (USA - WA) | Cancer - Oncology |
| 2018-05-08 | LB-001 | methylmalonic acidemia (MMA) | preclinical | LogicBio Therapeutics (USA - MA) | Rare diseases - Genetic diseases - Metabolic diseases |
| 2018-05-03 | CYAD-01 - NKR-2 (NKG2D CAR T-Cell) | metastatic colorectal cancer | 1 | Celyad (Belgium) | Cancer - Oncology |
| 2018-05-03 | CYAD-01 (CAR-T NKG2D) | colorectal cancer | 1 | Celyad (Belgium) | Cancer - Oncology |
| 2018-05-02 | alicaforsen enema | pouchitis | 3 | Atlantic Healthcare (UK) | Inflammatory diseases - Gastrointestinal diseases |
| 2018-05-01 | MOR106 | atopic dermatitis | 2 | Galapagos (Belgium) Morphosys (Germany) | Autoimmune diseases - Dermatological diseases |
| 2018-04-27 | THR-317 and ranibizumab | diabetic macular edema | 2 | Thrombogenics (Belgium) | Ophtalmological diseases |
| 2018-04-26 | burtomab (131-I-8H9), now omburtamab | desmoplastic small round cell tumor (DSRCT) | 1 | Y-mAbs Therapeutics (USA - NY) | Cancer - Oncology - Rare diseases |
